Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Ampio Pharmaceuticals Inc AMPE

Healthcare
Ampio Pharmaceuticals, Inc. is a drug discovery and development company. The Company is focused on combining scientific, clinical, and manufacturing capabilities to develop therapies aimed at treating conditions for which limited treatment options exist.

Recent & Breaking News (OTCPK:AMPE)

Ampio Pharmaceuticals' CEO Mike Martino Issues Letter to Stockholders

PR Newswire June 2, 2022

Ampio Pharmaceuticals Reports First-Quarter Financial Results

PR Newswire May 16, 2022

Ampio Independent Committee to Conduct Investigation

PR Newswire May 16, 2022

Ampio Pharmaceuticals, Inc. to Hold Conference Call

PR Newswire April 27, 2022

AMPIO PROVIDES REGULATORY UPDATE

PR Newswire April 20, 2022

Ampio Pharmaceuticals Reports Fourth-Quarter and Full-Year 2021 Financial Results and Operational Highlights

PR Newswire March 29, 2022

Ampio Pharmaceuticals, Inc. to Hold Fourth Quarter 2021 Earnings and Business Update Call

PR Newswire March 23, 2022

Ampio Pharmaceuticals to Participate at the 34th Annual Roth Conference

PR Newswire March 9, 2022

Ampio Pharmaceuticals, Inc. Releases Positive Phase 3 Data Analysis for Ampion(TM) Targeting Severe Osteoarthritis of the Knee (OAK)

PR Newswire March 2, 2022

Ampio Pharmaceuticals, Inc. to Host a Conference Call and Webinar

PR Newswire March 2, 2022

Ampio Expands Board of Directors with Addition of Elizabeth Varki Jobes

PR Newswire February 10, 2022

Ampio Pharmaceuticals Presents Corporate Overview at H.C. Wainwright Bioconnect Conference

PR Newswire January 6, 2022

Ampio Pharmaceuticals' CEO Mike Martino Issues Letter to Stockholders

PR Newswire December 16, 2021

AMPIO PHARMACEUTICALS ANNOUNCES PRICING OF $22.5 MILLION REGISTERED DIRECT OFFERING

PR Newswire December 13, 2021

Ampio Pharmaceuticals to Host Business Update Call with Chairman and CEO Mike Martino on Wednesday, Dec. 1

PR Newswire November 29, 2021

Ampio Pharmaceuticals Announces Shareholder / Business Update Call with its CEO & Chairman, Michael Martino

PR Newswire November 23, 2021

Board Member Michael Martino to Become Interim Chairman and CEO of Ampio Pharmaceuticals, Mike Macaluso to Take Medical Leave

PR Newswire November 22, 2021

Ampio Pharmaceuticals, Inc. Announces Third Quarter 2021 Financial Results and Provides Business Update

PR Newswire November 10, 2021

Ampio Pharmaceuticals, Inc. to Report Fiscal 2021 Third Quarter Financial Results and Provide Corporate Business Update

PR Newswire October 28, 2021

Ampio Pharmaceuticals Strengthens Management Team and Board of Directors

PR Newswire October 13, 2021